CooperCompanies will release Q3 2025 financial results on August 27, 2025, followed by a conference call at 5 PM ET.
Quiver AI Summary
CooperCompanies, a prominent medical device company based in San Ramon, California, announced that it will release its third quarter 2025 financial results on August 27, 2025, at 4:15 PM ET. Following the announcement, the company will hold a conference call at 5:00 PM ET to discuss the results and corporate updates, with a call-in number provided for participants. CooperCompanies operates through its two divisions, CooperVision, which focuses on contact lenses, and CooperSurgical, which specializes in fertility and women's healthcare. The company employs over 16,000 people, sells products in more than 130 countries, and impacts over fifty million lives annually. Further information can be found on their website.
Potential Positives
- CooperCompanies is preparing to report its third quarter 2025 financial results, indicating ongoing business activity and transparency with stakeholders.
- The company will host a conference call to discuss the financial results and corporate developments, demonstrating an engagement with investors and commitment to communication.
- CooperCompanies operates globally, positively impacting over fifty million lives each year, highlighting its significant market presence and contribution to healthcare.
- The announcement underscores the company's dual focus on vision and women's healthcare through its subsidiaries, CooperVision and CooperSurgical, showcasing diversification in its operations.
Potential Negatives
- None
FAQ
When will CooperCompanies report its Q3 2025 financial results?
CooperCompanies will report its Q3 2025 financial results on Wednesday, August 27, 2025, at 4:15 PM ET.
How can I access the Q3 conference call?
The conference call can be accessed by dialing 800-715-9871 with the conference ID 3665386.
Where can I find the webcast for the investor call?
The audio webcast and subsequent replay can be found at http://investor.coopercos.com.
What are the main business units of CooperCompanies?
CooperCompanies operates through two main units: CooperVision and CooperSurgical, focusing on vision and women's healthcare.
How many employees does CooperCompanies have?
CooperCompanies has a workforce of over 16,000 employees across the globe.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$COO Congressional Stock Trading
Members of Congress have traded $COO stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $COO stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$COO Hedge Fund Activity
We have seen 274 institutional investors add shares of $COO stock to their portfolio, and 363 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS added 3,557,989 shares (+84.9%) to their portfolio in Q1 2025, for an estimated $300,116,372
- VIKING GLOBAL INVESTORS LP removed 2,025,310 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $170,834,898
- IMPAX ASSET MANAGEMENT GROUP PLC removed 1,766,500 shares (-89.9%) from their portfolio in Q1 2025, for an estimated $149,004,275
- BANK OF AMERICA CORP /DE/ added 1,295,585 shares (+110.0%) to their portfolio in Q1 2025, for an estimated $109,282,594
- BALYASNY ASSET MANAGEMENT L.P. added 1,216,273 shares (+inf%) to their portfolio in Q1 2025, for an estimated $102,592,627
- AMERIPRISE FINANCIAL INC removed 1,211,101 shares (-41.5%) from their portfolio in Q1 2025, for an estimated $102,156,369
- NEUBERGER BERMAN GROUP LLC added 1,061,033 shares (+41.6%) to their portfolio in Q1 2025, for an estimated $89,498,133
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$COO Analyst Ratings
Wall Street analysts have issued reports on $COO in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 07/16/2025
- Needham issued a "Buy" rating on 06/17/2025
- Baird issued a "Outperform" rating on 05/30/2025
- Piper Sandler issued a "Overweight" rating on 05/30/2025
- Wells Fargo issued a "Overweight" rating on 05/30/2025
- Stifel issued a "Buy" rating on 03/07/2025
- Citigroup issued a "Buy" rating on 03/07/2025
To track analyst ratings and price targets for $COO, check out Quiver Quantitative's $COO forecast page.
$COO Price Targets
Multiple analysts have issued price targets for $COO recently. We have seen 8 analysts offer price targets for $COO in the last 6 months, with a median target of $95.5.
Here are some recent targets:
- Anthony Petrone from Mizuho set a target price of $90.0 on 07/16/2025
- David Saxon from Needham set a target price of $94.0 on 06/17/2025
- Jeff Johnson from Baird set a target price of $97.0 on 05/30/2025
- Jason Bednar from Piper Sandler set a target price of $105.0 on 05/30/2025
- Larry Biegelsen from Wells Fargo set a target price of $93.0 on 05/30/2025
- Robbie Marcus from JP Morgan set a target price of $76.0 on 05/30/2025
- Jonathan Block from Stifel set a target price of $105.0 on 03/07/2025
Full Release
SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday, August 27, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 3665386. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com .
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit
www.coopercos.com
.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
[email protected]
